Genetic and epigenetic studies of opioid abuse disorder - the potential for future diagnostics
- PMID: 37078260
- PMCID: PMC10257799
- DOI: 10.1080/14737159.2023.2190022
Genetic and epigenetic studies of opioid abuse disorder - the potential for future diagnostics
Abstract
Introduction: Opioid use disorder (OUD) is a global problem that often begins with prescribed medications. The available treatment and maintenance plans offer solutions for the consumption rate by individuals leaving the outstanding problem of relapse, which is a major factor hindering the long-term efficacy of treatments.
Areas covered: Understanding the neurobiology of addiction and relapse would help identifying the core causes of relapse and distinguish vulnerable from resilient individuals, which would lead to more targeted and effective treatment and provide diagnostics to screen individuals who have a propensity to OUD. In this review, we cover the neurobiology of the reward system highlighting the role of multiple brain regions and opioid receptors in the development of the disorder. We also review the current knowledge of the epigenetics of addiction and the available screening tools for aberrant use of opioids.
Expert opinion: Relapse remains an anticipated limitation in the way of recovery even after long period of abstinence. This highlights the need for diagnostic tools that identify vulnerable patients and prevent the cycle of addiction. Finally, we discuss the limitations of the available screening tools and propose possible solutions for the discovery of addiction diagnostics.
Keywords: Opioid; addiction; brain; circuitry; epigenetics; reward.
Conflict of interest statement
Declaration of interest
G.H. is a founder of Altomics Datamation Ltd. and a member of its scientific advisory board. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Figures


Similar articles
-
Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.Drugs. 2020 Oct;80(15):1509-1524. doi: 10.1007/s40265-020-01373-1. Drugs. 2020. PMID: 32776315 Free PMC article. Review.
-
Molecular and Epigenetic Aspects of Opioid Receptors in Drug Addiction and Pain Management in Sport.Int J Mol Sci. 2023 Apr 25;24(9):7831. doi: 10.3390/ijms24097831. Int J Mol Sci. 2023. PMID: 37175536 Free PMC article. Review.
-
Strategies to Identify Patient Risks of Prescription Opioid Addiction When Initiating Opioids for Pain: A Systematic Review.JAMA Netw Open. 2019 May 3;2(5):e193365. doi: 10.1001/jamanetworkopen.2019.3365. JAMA Netw Open. 2019. PMID: 31050783 Free PMC article.
-
Neural circuits controlling choice behavior in opioid addiction.Neuropharmacology. 2023 Mar 15;226:109407. doi: 10.1016/j.neuropharm.2022.109407. Epub 2022 Dec 30. Neuropharmacology. 2023. PMID: 36592884 Free PMC article. Review.
-
Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.Hosp Pract (1995). 2022 Oct;50(4):251-258. doi: 10.1080/21548331.2022.2102776. Epub 2022 Jul 22. Hosp Pract (1995). 2022. PMID: 35837678 Review.
Cited by
-
An Investigation of the RNA Modification m6A and Its Regulatory Enzymes in Rat Brains Affected by Chronic Morphine Treatment and Withdrawal.Int J Mol Sci. 2025 May 4;26(9):4371. doi: 10.3390/ijms26094371. Int J Mol Sci. 2025. PMID: 40362608 Free PMC article.
References
-
- Turton S, Lingford-Hughes A. Neurobiology and principles of addiction and tolerance. Medicine. 2020;48(12):749–753.
-
- Darcq E, Kieffer BL. Opioid receptors: drivers to addiction? Nature Reviews Neuroscience. 2018;19(8):499–514. - PubMed
-
- Hayes A, Herlinger K, Paterson L, et al. The neurobiology of substance use and addiction: evidence from neuroimaging and relevance to treatment. BJPsych Advances. 2020;26(6):367–378.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical